CFO LeBlanc Jeff Buys $245K of GRML Stock at $0.18 — 0.87% of Market Cap
GRML sits 18% above its 52-week low of $0.156.
Summary
Greenland Mines CFO LeBlanc Jeff bought 1.4 million shares for $245,280 at $0.1752, increasing his stake to 4.82 million shares. The open-market purchase represents 0.87% of the company's market cap and follows the July 16 shareholder vote on a major share authorization.
Key Events · Ownership and Investor Activity · GRML
-
CFO Buys $245K in Open Market
CFO LeBlanc Jeff purchased 1,400,000 shares at $0.1752 per share on July 16, 2026, for a total of $245,280. This is a Code P open-market purchase, not an option exercise or grant.
-
Stake Increases to 4.82M Shares
Post-transaction, LeBlanc directly owns 4,820,342 shares, worth approximately $887,000 at the current price of $0.184.
-
Purchase Represents 0.87% of Market Cap
The $245,280 buy equals 0.87% of Greenland Mines' $28.2 million market cap, a significant insider commitment for a nano-cap company.
-
Follows Critical Shareholder Vote
The purchase occurred one day after the July 16 special meeting where shareholders approved a massive 2-billion-share authorization, suggesting the CFO sees value despite potential dilution.
Analysis · GRML · Life Sciences
CFO LeBlanc Jeff just put $245,280 of his own money into Greenland Mines shares at $0.1752 — a purchase worth nearly 0.9% of the entire company. This is not an option exercise or a grant; it's an open-market buy, the strongest signal an insider can send. Coming just one day after the July 16 shareholder vote on a massive 2-billion-share authorization, the CFO is effectively telling the market he believes the stock is undervalued even with the dilution overhang. The company is burning cash, has a going-concern warning, and just closed a discounted placement — yet the CFO is buying, not selling. That's a notable vote of confidence in the Sarfartoq acquisition and the strategic plan.
How filings like this one have moved
In the 30 days to Oct 21, 2026, 37.2% of the 984 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.83%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, GRML was trading at $0.18 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $28.2M. The 52-week trading range was $0.16 to $1.38. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.